BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24709902)

  • 1. When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase.
    Brix DM; Clemmensen KK; Kallunki T
    Cells; 2014 Jan; 3(1):53-78. PubMed ID: 24709902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
    Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression.
    Rafn B; Nielsen CF; Andersen SH; Szyniarowski P; Corcelle-Termeau E; Valo E; Fehrenbacher N; Olsen CJ; Daugaard M; Egebjerg C; Bøttzauw T; Kohonen P; Nylandsted J; Hautaniemi S; Moreira J; Jäättelä M; Kallunki T
    Mol Cell; 2012 Mar; 45(6):764-76. PubMed ID: 22464443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB2, FoxM1 and 14-3-3ζ prime breast cancer cells for invasion in response to ionizing radiation.
    Kambach DM; Sodi VL; Lelkes PI; Azizkhan-Clifford J; Reginato MJ
    Oncogene; 2014 Jan; 33(5):589-98. PubMed ID: 23318431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.
    Tan M; Li P; Klos KS; Lu J; Lan KH; Nagata Y; Fang D; Jing T; Yu D
    Cancer Res; 2005 Mar; 65(5):1858-67. PubMed ID: 15753384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
    Spangenberg C; Lausch EU; Trost TM; Prawitt D; May A; Keppler R; Fees SA; Reutzel D; Bell C; Schmitt S; Schiffer IB; Weber A; Brenner W; Hermes M; Sahin U; Türeci O; Koelbl H; Hengstler JG; Zabel BU
    Cancer Res; 2006 Apr; 66(7):3715-25. PubMed ID: 16585198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mTORC2 as a necessary component of HRG/ErbB2-dependent cellular transformation.
    Lin MC; Rojas KS; Cerione RA; Wilson KF
    Mol Cancer Res; 2014 Jun; 12(6):940-52. PubMed ID: 24615340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Star-related lipid transfer protein 10 (STARD10): a novel key player in alcohol-induced breast cancer progression.
    Floris A; Luo J; Frank J; Zhou J; Orrù S; Biancolella M; Pucci S; Orlandi A; Campagna P; Balzano A; Ramani K; Tomasi ML
    J Exp Clin Cancer Res; 2019 Jan; 38(1):4. PubMed ID: 30611309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.
    Chang J; Nicolau MM; Cox TR; Wetterskog D; Martens JW; Barker HE; Erler JT
    Breast Cancer Res; 2013; 15(4):R67. PubMed ID: 23971878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.
    Liu B; Ordonez-Ercan D; Fan Z; Edgerton SM; Yang X; Thor AD
    Int J Cancer; 2007 May; 120(9):1874-82. PubMed ID: 17266042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases.
    Spencer KS; Graus-Porta D; Leng J; Hynes NE; Klemke RL
    J Cell Biol; 2000 Jan; 148(2):385-97. PubMed ID: 10648571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB2 and the antimetastatic nm23/NDP kinase in regulating serum induced breast cancer invasion.
    Tommasi S; Fedele V; Crapolicchio A; Bellizzi A; Paradiso A; Reshkin SJ
    Int J Mol Med; 2003 Jul; 12(1):131-4. PubMed ID: 12792823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of ErbB2 induces invasion of MCF10A human breast epithelial cells via MMP-9.
    Kim IY; Yong HY; Kang KW; Moon A
    Cancer Lett; 2009 Mar; 275(2):227-33. PubMed ID: 19022565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-133a-3p suppresses malignant behavior of non-small cell lung cancer cells by negatively regulating ERBB2.
    Xu Y; Zhang L; Xia L; Zhu X
    Oncol Lett; 2021 Jun; 21(6):457. PubMed ID: 33907567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer.
    Ortega-Cava CF; Raja SM; Laiq Z; Bailey TA; Luan H; Mohapatra B; Williams SH; Ericsson AC; Goswami R; Dimri M; Duan L; Band V; Naramura M; Band H
    J Carcinog; 2011; 10():29. PubMed ID: 22190871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
    Yoshida K; Tsuda M; Matsumoto R; Semba S; Wang L; Sugino H; Tanino M; Kondo T; Tanabe K; Tanaka S
    Cancer Sci; 2019 Jul; 110(7):2119-2132. PubMed ID: 31141251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
    Zhan L; Xiang B; Muthuswamy SK
    Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression.
    Yang W; Klos KS; Zhou X; Yao J; Yang Y; Smith TL; Shi D; Yu D
    Cancer; 2003 Sep; 98(6):1123-30. PubMed ID: 12973835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer.
    Wolfson E; Goldenberg M; Solomon S; Frishberg A; Pinkas-Kramarski R
    Oncotarget; 2016 Oct; 7(40):65320-65334. PubMed ID: 27542246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.